Hemopure hemoglobin glutamer regulatory update

BPUR submitted a BLA to the FDA for Hemopure to treat acute anemia in adults undergoing orthopedic surgery, and to eliminate or reduce red blood cell transfusions in these patients. In December, BPUR ...